| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Cytoplasmic and Nuclear | 26 | 2017 | 321 | 6.020 |
Why?
|
| Signal Transduction | 21 | 2020 | 4485 | 2.280 |
Why?
|
| Transcriptome | 9 | 2020 | 1068 | 2.130 |
Why?
|
| Internet | 10 | 2017 | 402 | 1.320 |
Why?
|
| Databases, Genetic | 4 | 2017 | 481 | 1.100 |
Why?
|
| Computational Biology | 5 | 2020 | 835 | 0.970 |
Why?
|
| Datasets as Topic | 4 | 2020 | 102 | 0.920 |
Why?
|
| Periodicals as Topic | 3 | 2014 | 180 | 0.870 |
Why?
|
| Information Dissemination | 5 | 2017 | 189 | 0.860 |
Why?
|
| Gene Expression Regulation | 9 | 2017 | 2312 | 0.850 |
Why?
|
| Gene Expression Profiling | 12 | 2025 | 1774 | 0.830 |
Why?
|
| Dermatologic Agents | 1 | 2023 | 29 | 0.780 |
Why?
|
| Information Management | 2 | 2012 | 7 | 0.770 |
Why?
|
| Psoriasis | 1 | 2023 | 52 | 0.760 |
Why?
|
| Software | 4 | 2017 | 711 | 0.740 |
Why?
|
| Information Storage and Retrieval | 2 | 2012 | 61 | 0.660 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 2020 | 45 | 0.630 |
Why?
|
| Thyroid Hormones | 1 | 2020 | 55 | 0.620 |
Why?
|
| Thyroid Gland | 1 | 2020 | 99 | 0.610 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2020 | 236 | 0.600 |
Why?
|
| Databases, Factual | 3 | 2019 | 1194 | 0.590 |
Why?
|
| Endocrinology | 2 | 2012 | 128 | 0.580 |
Why?
|
| Animals | 39 | 2025 | 33197 | 0.530 |
Why?
|
| Transcription Factors | 9 | 2022 | 2344 | 0.520 |
Why?
|
| Phagosomes | 3 | 2024 | 37 | 0.520 |
Why?
|
| Trans-Activators | 5 | 2008 | 676 | 0.520 |
Why?
|
| Receptors, Steroid | 2 | 2016 | 162 | 0.510 |
Why?
|
| Genes | 1 | 2017 | 304 | 0.500 |
Why?
|
| Research | 2 | 2014 | 256 | 0.470 |
Why?
|
| Atlases as Topic | 1 | 2015 | 20 | 0.470 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 363 | 0.460 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 376 | 0.460 |
Why?
|
| Biomedical Research | 3 | 2017 | 534 | 0.430 |
Why?
|
| Humans | 49 | 2025 | 127335 | 0.370 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2012 | 75 | 0.370 |
Why?
|
| User-Computer Interface | 2 | 2010 | 155 | 0.360 |
Why?
|
| Tretinoin | 1 | 2012 | 93 | 0.360 |
Why?
|
| Repressor Proteins | 3 | 2008 | 763 | 0.350 |
Why?
|
| Selective Estrogen Receptor Modulators | 2 | 2001 | 52 | 0.340 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2013 | 1005 | 0.330 |
Why?
|
| Co-Repressor Proteins | 1 | 2010 | 37 | 0.330 |
Why?
|
| Databases, Protein | 2 | 2010 | 59 | 0.320 |
Why?
|
| Epigenesis, Genetic | 2 | 2025 | 711 | 0.310 |
Why?
|
| Access to Information | 1 | 2009 | 45 | 0.300 |
Why?
|
| Estradiol | 3 | 2009 | 477 | 0.300 |
Why?
|
| Mice, Inbred C57BL | 6 | 2025 | 4513 | 0.290 |
Why?
|
| Mice | 20 | 2025 | 17686 | 0.290 |
Why?
|
| Publishing | 1 | 2009 | 104 | 0.280 |
Why?
|
| Gene Expression | 4 | 2020 | 1485 | 0.260 |
Why?
|
| Macrophages | 3 | 2022 | 644 | 0.260 |
Why?
|
| Terminology as Topic | 1 | 2008 | 224 | 0.250 |
Why?
|
| Adipocytes | 3 | 2013 | 168 | 0.250 |
Why?
|
| Genomics | 4 | 2017 | 1548 | 0.250 |
Why?
|
| Gene Regulatory Networks | 4 | 2021 | 359 | 0.240 |
Why?
|
| Biology | 1 | 2005 | 25 | 0.230 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2025 | 38 | 0.230 |
Why?
|
| Cross-Priming | 1 | 2024 | 5 | 0.230 |
Why?
|
| Plasma Cells | 1 | 2025 | 54 | 0.220 |
Why?
|
| Histones | 3 | 2025 | 503 | 0.220 |
Why?
|
| Cold-Shock Response | 1 | 2024 | 5 | 0.220 |
Why?
|
| Models, Biological | 5 | 2016 | 1374 | 0.210 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2024 | 119 | 0.210 |
Why?
|
| Pulmonary Fibrosis | 1 | 2025 | 111 | 0.210 |
Why?
|
| Trophoblasts | 1 | 2025 | 113 | 0.210 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2024 | 440 | 0.210 |
Why?
|
| Adipose Tissue, Brown | 1 | 2024 | 85 | 0.210 |
Why?
|
| Lymphadenopathy | 1 | 2024 | 31 | 0.210 |
Why?
|
| Sarcoidosis | 1 | 2023 | 50 | 0.200 |
Why?
|
| Emphysema | 1 | 2024 | 62 | 0.200 |
Why?
|
| Pre-Eclampsia | 1 | 2025 | 220 | 0.190 |
Why?
|
| Fibrosis | 1 | 2024 | 400 | 0.190 |
Why?
|
| Pulmonary Emphysema | 1 | 2024 | 91 | 0.190 |
Why?
|
| Ligands | 3 | 2016 | 477 | 0.190 |
Why?
|
| Pathogen-Associated Molecular Pattern Molecules | 1 | 2022 | 5 | 0.190 |
Why?
|
| Antigens, Neoplasm | 1 | 2025 | 398 | 0.180 |
Why?
|
| Cathepsin Z | 1 | 2021 | 1 | 0.180 |
Why?
|
| Receptors, Progesterone | 3 | 2020 | 664 | 0.180 |
Why?
|
| Dendritic Cells | 1 | 2024 | 435 | 0.180 |
Why?
|
| Cell Differentiation | 6 | 2025 | 1868 | 0.180 |
Why?
|
| Steroids | 1 | 2002 | 158 | 0.180 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2025 | 316 | 0.170 |
Why?
|
| Proteomics | 3 | 2024 | 563 | 0.170 |
Why?
|
| Receptors, Estrogen | 2 | 2003 | 714 | 0.170 |
Why?
|
| Neoplasm Proteins | 1 | 2025 | 656 | 0.170 |
Why?
|
| Placenta | 1 | 2025 | 518 | 0.170 |
Why?
|
| Interferon Regulatory Factors | 1 | 2020 | 43 | 0.170 |
Why?
|
| Fibroblasts | 1 | 2024 | 820 | 0.170 |
Why?
|
| Middle East Respiratory Syndrome Coronavirus | 1 | 2020 | 22 | 0.170 |
Why?
|
| Inflammasomes | 1 | 2021 | 149 | 0.160 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2025 | 484 | 0.160 |
Why?
|
| Receptors, Androgen | 2 | 2013 | 403 | 0.160 |
Why?
|
| Knowledge Bases | 1 | 2019 | 38 | 0.160 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2021 | 253 | 0.150 |
Why?
|
| Double-Blind Method | 1 | 2023 | 1596 | 0.150 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2021 | 219 | 0.150 |
Why?
|
| Glucose | 1 | 2023 | 839 | 0.150 |
Why?
|
| Transcription, Genetic | 2 | 2012 | 1380 | 0.150 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2023 | 542 | 0.150 |
Why?
|
| DNA Replication | 1 | 2020 | 346 | 0.140 |
Why?
|
| Mammals | 1 | 2019 | 247 | 0.140 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2022 | 517 | 0.140 |
Why?
|
| Schizophrenia | 1 | 2021 | 320 | 0.140 |
Why?
|
| MicroRNAs | 1 | 2025 | 872 | 0.140 |
Why?
|
| Cell Cycle | 1 | 2020 | 587 | 0.140 |
Why?
|
| Breast Neoplasms | 2 | 2009 | 2586 | 0.140 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2023 | 393 | 0.140 |
Why?
|
| Metabolomics | 2 | 2012 | 455 | 0.140 |
Why?
|
| Antipsychotic Agents | 1 | 2021 | 373 | 0.140 |
Why?
|
| Interferon-gamma | 2 | 2023 | 528 | 0.140 |
Why?
|
| Consensus | 1 | 2020 | 558 | 0.140 |
Why?
|
| Liver | 3 | 2023 | 1765 | 0.130 |
Why?
|
| DNA Methylation | 1 | 2024 | 1032 | 0.130 |
Why?
|
| Metadata | 1 | 2017 | 6 | 0.130 |
Why?
|
| Betacoronavirus | 1 | 2020 | 285 | 0.130 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2024 | 630 | 0.130 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2017 | 132 | 0.130 |
Why?
|
| Xenobiotics | 1 | 2016 | 27 | 0.120 |
Why?
|
| Organ Specificity | 1 | 2017 | 395 | 0.120 |
Why?
|
| Data Mining | 1 | 2016 | 58 | 0.120 |
Why?
|
| Lung Neoplasms | 1 | 2025 | 1493 | 0.110 |
Why?
|
| Vibrio parahaemolyticus | 1 | 2014 | 7 | 0.110 |
Why?
|
| Oxidoreductases | 1 | 2014 | 99 | 0.110 |
Why?
|
| Nuclear Receptor Coactivator 1 | 5 | 2003 | 161 | 0.100 |
Why?
|
| Histone Acetyltransferases | 5 | 2003 | 224 | 0.100 |
Why?
|
| Cell Proliferation | 1 | 2021 | 2398 | 0.100 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2014 | 96 | 0.100 |
Why?
|
| Molecular Chaperones | 1 | 2014 | 169 | 0.100 |
Why?
|
| Pandemics | 1 | 2020 | 1140 | 0.100 |
Why?
|
| Two-Dimensional Difference Gel Electrophoresis | 1 | 2012 | 4 | 0.100 |
Why?
|
| National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) | 1 | 2012 | 8 | 0.100 |
Why?
|
| Adipogenesis | 1 | 2013 | 80 | 0.090 |
Why?
|
| Androgen Receptor Antagonists | 1 | 2012 | 40 | 0.090 |
Why?
|
| Review Literature as Topic | 1 | 2012 | 50 | 0.090 |
Why?
|
| Osteogenesis | 1 | 2013 | 162 | 0.090 |
Why?
|
| Protein Array Analysis | 1 | 2012 | 107 | 0.090 |
Why?
|
| Academies and Institutes | 1 | 2012 | 80 | 0.090 |
Why?
|
| Zebrafish Proteins | 1 | 2012 | 121 | 0.090 |
Why?
|
| DNA Primers | 1 | 2012 | 604 | 0.090 |
Why?
|
| Data Interpretation, Statistical | 1 | 2012 | 221 | 0.090 |
Why?
|
| Embryonic Stem Cells | 1 | 2012 | 161 | 0.090 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 1 | 2010 | 9 | 0.090 |
Why?
|
| Mass Spectrometry | 1 | 2012 | 350 | 0.090 |
Why?
|
| Androgens | 1 | 2013 | 269 | 0.080 |
Why?
|
| Congresses as Topic | 1 | 2012 | 175 | 0.080 |
Why?
|
| Mice, Knockout | 4 | 2024 | 3718 | 0.080 |
Why?
|
| Data Collection | 1 | 2012 | 370 | 0.080 |
Why?
|
| Proteome | 1 | 2012 | 274 | 0.080 |
Why?
|
| Testis | 1 | 2012 | 405 | 0.080 |
Why?
|
| NF-kappa B | 1 | 2012 | 438 | 0.080 |
Why?
|
| Glucocorticoids | 1 | 2012 | 337 | 0.080 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 524 | 0.080 |
Why?
|
| Zebrafish | 1 | 2012 | 403 | 0.080 |
Why?
|
| Ovary | 1 | 2012 | 358 | 0.080 |
Why?
|
| Cell Line, Tumor | 2 | 2025 | 3502 | 0.080 |
Why?
|
| Disease | 1 | 2010 | 123 | 0.080 |
Why?
|
| Health Resources | 1 | 2010 | 127 | 0.080 |
Why?
|
| GATA2 Transcription Factor | 1 | 2009 | 46 | 0.070 |
Why?
|
| Bacterial Proteins | 1 | 2014 | 913 | 0.070 |
Why?
|
| Oxidation-Reduction | 2 | 2023 | 424 | 0.070 |
Why?
|
| PPAR gamma | 1 | 2009 | 86 | 0.070 |
Why?
|
| International Cooperation | 1 | 2009 | 158 | 0.070 |
Why?
|
| Cholestasis | 1 | 2010 | 166 | 0.070 |
Why?
|
| Principal Component Analysis | 1 | 2009 | 148 | 0.070 |
Why?
|
| Nuclear Proteins | 2 | 2008 | 1205 | 0.070 |
Why?
|
| Cell Nucleus | 1 | 2010 | 551 | 0.070 |
Why?
|
| Pilot Projects | 1 | 2012 | 1400 | 0.070 |
Why?
|
| Treatment Outcome | 1 | 2023 | 12572 | 0.070 |
Why?
|
| Lung | 2 | 2025 | 1522 | 0.060 |
Why?
|
| Acetylation | 2 | 2025 | 181 | 0.060 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 658 | 0.060 |
Why?
|
| Cell Line | 4 | 2012 | 2565 | 0.060 |
Why?
|
| Rats | 1 | 2012 | 3395 | 0.060 |
Why?
|
| Systems Integration | 1 | 2006 | 25 | 0.060 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2025 | 30 | 0.060 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2025 | 66 | 0.060 |
Why?
|
| Apolipoproteins L | 1 | 2024 | 1 | 0.060 |
Why?
|
| HeLa Cells | 2 | 2014 | 684 | 0.060 |
Why?
|
| Inflammation | 2 | 2022 | 1433 | 0.050 |
Why?
|
| Antigen Presentation | 1 | 2024 | 116 | 0.050 |
Why?
|
| Bleomycin | 1 | 2024 | 110 | 0.050 |
Why?
|
| Models, Genetic | 2 | 2012 | 742 | 0.050 |
Why?
|
| Cold Temperature | 1 | 2024 | 81 | 0.050 |
Why?
|
| Histone Code | 1 | 2024 | 45 | 0.050 |
Why?
|
| Thermogenesis | 1 | 2024 | 50 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2025 | 192 | 0.050 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2024 | 134 | 0.050 |
Why?
|
| Protein Binding | 2 | 2014 | 1663 | 0.050 |
Why?
|
| Flavin-Adenine Dinucleotide | 1 | 2023 | 9 | 0.050 |
Why?
|
| Flavoproteins | 1 | 2023 | 20 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2024 | 578 | 0.050 |
Why?
|
| PPAR alpha | 1 | 2023 | 53 | 0.050 |
Why?
|
| 3T3-L1 Cells | 2 | 2013 | 52 | 0.050 |
Why?
|
| Scleroderma, Systemic | 1 | 2024 | 127 | 0.050 |
Why?
|
| Pyridines | 1 | 2024 | 251 | 0.050 |
Why?
|
| Substrate Specificity | 2 | 2000 | 280 | 0.050 |
Why?
|
| Ubiquitination | 1 | 2023 | 168 | 0.050 |
Why?
|
| Alarmins | 1 | 2022 | 5 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2006 | 1484 | 0.050 |
Why?
|
| Organoids | 1 | 2025 | 282 | 0.050 |
Why?
|
| Integrin alpha5 | 1 | 2021 | 5 | 0.050 |
Why?
|
| Silicosis | 1 | 2021 | 4 | 0.050 |
Why?
|
| Fasting | 1 | 2023 | 300 | 0.050 |
Why?
|
| Single-Cell Analysis | 1 | 2025 | 314 | 0.050 |
Why?
|
| Silicon Dioxide | 1 | 2021 | 31 | 0.050 |
Why?
|
| Macromolecular Substances | 2 | 1999 | 141 | 0.050 |
Why?
|
| Skin | 1 | 2024 | 517 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2023 | 348 | 0.040 |
Why?
|
| Pyrimidines | 1 | 2024 | 407 | 0.040 |
Why?
|
| Interleukin-1beta | 1 | 2021 | 150 | 0.040 |
Why?
|
| Phagocytosis | 1 | 2022 | 191 | 0.040 |
Why?
|
| United States | 2 | 2017 | 11386 | 0.040 |
Why?
|
| Fatty Acids | 1 | 2023 | 351 | 0.040 |
Why?
|
| Kinetics | 2 | 2003 | 1092 | 0.040 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2000 | 33 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2013 | 1015 | 0.040 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2021 | 125 | 0.040 |
Why?
|
| Female | 6 | 2025 | 68638 | 0.040 |
Why?
|
| Recombinant Proteins | 2 | 2003 | 1295 | 0.040 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2000 | 270 | 0.040 |
Why?
|
| Tamoxifen | 1 | 2000 | 345 | 0.040 |
Why?
|
| POU Domain Factors | 1 | 1998 | 8 | 0.040 |
Why?
|
| Molecular Sequence Data | 4 | 2014 | 3587 | 0.040 |
Why?
|
| Ligases | 1 | 1998 | 34 | 0.040 |
Why?
|
| Weight Gain | 1 | 2021 | 377 | 0.040 |
Why?
|
| CREB-Binding Protein | 1 | 1998 | 55 | 0.040 |
Why?
|
| RNA Polymerase II | 1 | 1998 | 90 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2025 | 3325 | 0.030 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 1998 | 144 | 0.030 |
Why?
|
| Acetyltransferases | 1 | 1997 | 72 | 0.030 |
Why?
|
| Homeostasis | 1 | 2001 | 690 | 0.030 |
Why?
|
| Sequence Deletion | 2 | 2014 | 511 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2000 | 1206 | 0.030 |
Why?
|
| Knowledge | 1 | 2017 | 48 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 1998 | 412 | 0.030 |
Why?
|
| Transfection | 1 | 1998 | 948 | 0.030 |
Why?
|
| Chromatin | 1 | 1999 | 472 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 1998 | 350 | 0.030 |
Why?
|
| RNA | 1 | 1999 | 518 | 0.030 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 1997 | 260 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2014 | 680 | 0.030 |
Why?
|
| Male | 5 | 2025 | 62795 | 0.030 |
Why?
|
| Cysteine Proteases | 1 | 2014 | 7 | 0.030 |
Why?
|
| Oxidoreductases Acting on Sulfur Group Donors | 1 | 2014 | 30 | 0.030 |
Why?
|
| Cathepsins | 1 | 2014 | 27 | 0.030 |
Why?
|
| Disulfides | 1 | 2014 | 78 | 0.030 |
Why?
|
| Antigens | 1 | 2014 | 146 | 0.030 |
Why?
|
| Endosomes | 1 | 2014 | 62 | 0.030 |
Why?
|
| Bacterial Secretion Systems | 1 | 2014 | 5 | 0.030 |
Why?
|
| NADPH Oxidases | 1 | 2014 | 108 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2014 | 2543 | 0.030 |
Why?
|
| Protein Interaction Mapping | 1 | 2014 | 90 | 0.030 |
Why?
|
| Proteolysis | 1 | 2014 | 178 | 0.030 |
Why?
|
| Biological Transport | 1 | 2014 | 326 | 0.030 |
Why?
|
| Metribolone | 1 | 2013 | 28 | 0.030 |
Why?
|
| Testosterone Congeners | 1 | 2013 | 15 | 0.030 |
Why?
|
| Lentivirus | 1 | 2013 | 79 | 0.020 |
Why?
|
| Deoxycholic Acid | 1 | 2012 | 14 | 0.020 |
Why?
|
| Sex Differentiation | 1 | 2012 | 16 | 0.020 |
Why?
|
| Support Vector Machine | 1 | 2012 | 23 | 0.020 |
Why?
|
| Lysosomes | 1 | 2014 | 248 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2014 | 586 | 0.020 |
Why?
|
| Dihydrotestosterone | 1 | 2012 | 72 | 0.020 |
Why?
|
| Pregnancy | 1 | 2025 | 7402 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 787 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2012 | 138 | 0.020 |
Why?
|
| Osteoblasts | 1 | 2013 | 160 | 0.020 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2012 | 105 | 0.020 |
Why?
|
| Transgenes | 1 | 2013 | 330 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 493 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2012 | 566 | 0.020 |
Why?
|
| Ovarian Neoplasms | 1 | 1995 | 443 | 0.020 |
Why?
|
| Oxygen | 1 | 2014 | 541 | 0.020 |
Why?
|
| Steroid 12-alpha-Hydroxylase | 1 | 2010 | 5 | 0.020 |
Why?
|
| Mice, Congenic | 1 | 2010 | 16 | 0.020 |
Why?
|
| 17-alpha-Hydroxyprogesterone | 1 | 2010 | 8 | 0.020 |
Why?
|
| Biliary Tract | 1 | 2010 | 11 | 0.020 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2010 | 32 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2010 | 97 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 1998 | 1891 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 1232 | 0.020 |
Why?
|
| Bile Acids and Salts | 1 | 2010 | 243 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2013 | 2541 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2012 | 962 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2012 | 2898 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2009 | 355 | 0.010 |
Why?
|
| Apoptosis | 1 | 2012 | 1824 | 0.010 |
Why?
|
| Adult | 1 | 2025 | 30544 | 0.010 |
Why?
|
| Biomarkers | 1 | 2013 | 3235 | 0.010 |
Why?
|
| Base Sequence | 2 | 1999 | 2759 | 0.010 |
Why?
|
| Xenopus | 1 | 2003 | 103 | 0.010 |
Why?
|
| Estrogen Receptor beta | 1 | 2003 | 81 | 0.010 |
Why?
|
| Oocytes | 1 | 2003 | 280 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 4446 | 0.010 |
Why?
|
| Estrogen Receptor alpha | 1 | 2003 | 424 | 0.010 |
Why?
|
| Phenotype | 1 | 2009 | 4308 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2003 | 891 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1999 | 252 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1999 | 435 | 0.010 |
Why?
|
| Multiprotein Complexes | 1 | 1999 | 191 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1997 | 136 | 0.010 |
Why?
|
| Nucleosomes | 1 | 1997 | 32 | 0.010 |
Why?
|
| p300-CBP Transcription Factors | 1 | 1997 | 44 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1997 | 260 | 0.010 |
Why?
|
| COS Cells | 1 | 1997 | 244 | 0.010 |
Why?
|
| Chickens | 1 | 1997 | 284 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 1997 | 144 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1997 | 784 | 0.010 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1995 | 48 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1995 | 138 | 0.010 |
Why?
|
| Binding Sites | 1 | 1997 | 1186 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1995 | 348 | 0.010 |
Why?
|
| Introns | 1 | 1995 | 281 | 0.010 |
Why?
|
| RNA Splicing | 1 | 1995 | 230 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 1997 | 677 | 0.010 |
Why?
|
| Alleles | 1 | 1995 | 1609 | 0.010 |
Why?
|